STJ  St. Jude Medical Inc.

Exchange

NYSE

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.

17.415B

Vuru Grade

63.93/100

Current Price

$60.05
+0.03 (+0.05%)

Growth Price

$38.83
Overvalued by 35.34%

Stability Price

$20.11
Overvalued by 66.51%

Company Metrics

  • 19.83 P/E
  • 3.11 P/S
  • 4.2 P/B
  • 3.027 EPS
  • 13.07% Cash ROIC
  • 0.99 Cash Ratio
  • 1.06 / 1.77% Dividend
  • 1.67M Avg. Vol.
  • 290.01M Shares
  • 17.415B Market Cap.

Company Description

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Post-Earnings Analyst Review - St. Jude Medical
CNNMoney - Oct 22, 2014
Investor-Edge.com has issued free post-earnings analyst review on St. Jude Medical Inc. (NYSE: STJ). On October 15, 2014, the company reported its financial results for Q3 FY14 (period ended September 27, 2014).
Why St. Jude Medical (STJ) Stock Is Declining Today
TheStreet.com - Oct 15, 2014
ST JUDE MEDICAL INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago.
St. Jude Medical lowers forecast; shares fall - Reuters
Shares in St. Jude Medical fall after outlook darkens - Minneapolis Star Tribune
St. Jude Medical, Inc. Announces Quarterly Dividend of $0.27 (STJ)
Ticker Report - Oct 21, 2014
St. Jude Medical logo St. Jude Medical (NYSE:STJ) announced a quarterly dividend on Tuesday, October 21st, ARN reports.
St. Jude Medical Announces Fourth Quarter Dividend - Finances.com
Bank Of America Tweaks Numbers For St. Jude Medical, Inc. Lower On F/X, Portico
Benzinga - Oct 6, 2014
In a report published Monday, Bank of America analyst Bob Hopkins reiterated a Buy rating and $80.00 price target on St. Jude Medical, Inc. (NYSE: STJ). In the report, Bank of America noted, “Given F/X moves since STJ's Q2 call and STJ's guidance that ...
First Week of December 20th Options Trading For St. Jude Medical (STJ)
Forbes - Oct 21, 2014
Investors in St. Jude Medical, Inc. (NYSE: STJ) saw new options begin trading this week, for the December 20th expiration.
St. Jude To Report Q3 Earnings This Week
Bidness ETC - Oct 13, 2014
St. Jude is expected to report revenues of $1.38 billion, up 3% year-over-year (YoY) on the back of anticipated robust increases in the sales from the Cardiovascular and Atrial Fibrillation segments.
St. Jude Medical Gets CE Mark for Pacing Lead Labeling
Zacks.com - Sep 23, 2014
St. Jude Medical Inc. (STJ - Analyst Report) revealed that it has received Conformité Européene (CE) Mark approval of updated labeling for its Tendril STS and IsoFlex Optim pacing leads.
St. Jude Medical, Inc. (STJ) Ex-Dividend Date Scheduled for September 26, 2014
NASDAQ - Sep 25, 2014
St. Jude Medical, Inc. ( STJ ) will begin trading ex-dividend on September 26, 2014. A cash dividend payment of $0.27 per share is scheduled to be paid on October 31, 2014.
Zacks Reiterates Neutral Rating for St. Jude Medical (STJ)
Ticker Report - Oct 20, 2014
St. Jude Medical, Inc. logo Zacks reiterated their neutral rating on shares of St. Jude Medical (NYSE:STJ) in a research note released on Thursday morning.
St. Jude Medical Price Target Lowered to $47.00 at Canaccord Genuity (STJ) - Mideast Time
St. Jude Medical tightens guidance after Q3 results (STJ)
Seeking Alpha (registration) - Oct 15, 2014
St. Jude Medical (NYSE:STJ) Q3 results: Revenues: $1,372M (+2.5%); International: $706M (+2.0%); U.S.: $666M (+3.1%); WW Cardiac Rhythm Management (CRM): $688M (-0.3%); International CRM: $315M (-2.2%); U.S.